in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Dr. Reddy’s API Site in Mexico Receives U.S. FDA Warning
11:39 AM MDT | June 17, 2011 | Deepti Ramesh
Pharmaceutical company Dr. Reddy’s Laboratories (Hyderabad, India) says that Industrias Quimicas Falcon de Mexico, its wholly owned manufacturing facility at Cuernavaca, Mexico has received a warning letter from the U.S. Food and Drug Administration (FDA). The facility produces intermediates and active pharmaceutical ingredients (API). An FDA inspection of the Cuernavaca facility in November 2010 identified certain deviations from current good manufacturing practice (cGMP) for the manufacture of APIs, the FDA says. Dr. Reddy’s says it responded to the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee